Artemis Therapeutics, Inc. (ATMS)

OTCMKTS: ATMS · Delayed Price · USD
1.30
0.00 (0.00%)
Dec 9, 2022 4:00 PM EST - Market closed
Market Cap 145.64M
Revenue (ttm) n/a
Net Income (ttm) 197,000
Shares Out 112.03M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5
Open 1.4
Previous Close 1.3
Day's Range 1.3 - 1.3
52-Week Range 0.55 - 5
Beta -1.08
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2022

About ATMS

Artemis Therapeutics Inc., a beauty company, develops and distributes skincare products in Israel. The company offers face serum with manuka honey and bee venom, face serum with enhanced vitamin C, day cream, night nourishing cream with manuka honey and nee venom, eye cream with manuka honey and bee venom, and face cleanser gel. It also distributes manuka honey imported from New Zealand. The company was incorporated in 2020 and is based in Ramat Gan, Israel. [Read more]

Industry Pharmaceuticals
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol ATMS
Full Company Profile

News

There is no news available yet.